Renal-Limited Antiglomerular Basement Membrane Disease Related To Alemtuzumab: A Case Report

RATIONALE: Alemtuzumab is a monoclonal antibody approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). Many autoimmune-mediated adverse events have been associated with alemtuzumab, including renal-limited anti-glomerular basement membrane (GBM) disease. PRESENTING CONCERN: A 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrigan, Amye M., West, Michael L., Geldenhuys, Laurette, Poyah, Penelope
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Educational Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573726/
https://www.ncbi.nlm.nih.gov/pubmed/33117548
http://dx.doi.org/10.1177/2054358120962680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573726/
https://www.ncbi.nlm.nih.gov/pubmed/33117548
http://dx.doi.org/10.1177/2054358120962680

Ejemplares similares